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Background: Trisomy 9p is one of the most common partial trisomies found in newborns. We report the clinical
features and cytogenomic findings in five patients with different chromosome rearrangements resulting in complete
9p duplication, three of them involving 9p centromere alterations.
Methods: The rearrangements in the patients were characterized by G-banding, SNP-array and fluorescent in situ
hybridization (FISH) with different probes.
Results: Two patients presented de novo dicentric chromosomes: der(9;15)t(9;15)(p11.2;p13) and der(9;21)t(9;21)
(p13.1;p13.1). One patient presented two concomitant rearranged chromosomes: a der(12)t(9;12)(q21.13;p13.33)
and an psu i(9)(p10) which showed FISH centromeric signal smaller than in the normal chromosome 9. Besides the
duplication 9p24.3p13.1, array revealed a 7.3 Mb deletion in 9q13q21.13 in this patient. The break in the psu i(9)
(p10) probably occurred in the centromere resulting in a smaller centromere and with part of the 9q translocated
to the distal 12p with the deletion 9q occurring during this rearrangement. Two patients, brother and sister, present 9p
duplication concomitant to 18p deletion due to an inherited der(18)t(9;18)(p11.2;p11.31)mat.
Conclusions: The patients with trisomy 9p present a well-recognizable phenotype due to facial appearance, although
the genotype-phenotype correlation can be difficult due to concomitant partial monosomy of other chromosomes.
The chromosome 9 is rich in segmental duplication, especially in pericentromeric region, with high degree of sequence
identity to sequences in 15p, 18p and 21p, chromosomes involved in our rearrangements. Thus, we suggest that
chromosome 9 is prone to illegitimate recombination, either intrachromosomal or interchromosomal, which
predisposes it to rearrangements, frequently involving pericentromeric regions.
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Since the report of a 9p duplication by Rethore et al. [1],
more than 150 patients have been reported in the lite-
rature. Trisomy 9p, together with trisomy 21, 18 and 13
are the most common trisomies found in newborns. A
possible explanation might be that 9p chromosome is rela-
tively poor in genes and therefore more compatible with
survival [2]. In general, there is a remarkable consistency
in the phenotype, especially in facial and digital anomalies,
despite of variations in the size of the duplication [3,4].
Other features include short stature, microcephaly/brachy-
cephaly, downslanting palpebral fissures, deep set eyes,* Correspondence: melaragno.maria@unifesp.br
1Department of Morphology and Genetics, Universidade Federal de São
Paulo, Rua Botucatu 740, CEP 04023-900 São Paulo, Brazil
Full list of author information is available at the end of the article
© 2014 Guilherme et al.; licensee BioMed Cen
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.hypertelorism, short wide neck, globular/prominent nose,
short philtrum, downturned corners of the mouth, low set
ears, development delay, anomalies of hands and toes and
variable degree of intellectual disability [3,5-7]. Trisomy
for 9pter→ p11 is associated with typical craniofacial
features, while trisomy for 9pter→ q11-13 shows skel-
etal and cardiac defects in addition to the craniofacial
features [8]. The degree of clinical severity is related to
the extension of the 9p duplicated segment [5] but
phenotype-genotype correlation studies suggested that
the minimal critical region for the classical trisomy 9p is
located in 9p22→ p24 [7,9] while Christ et al. [10] pro-
posed a shorter region 9p22.1→ p23.
In most cases partial 9p trisomy was the result of paren-
tal reciprocal translocations between chromosome 9 and
another autosome [11]. Direct 9p duplication was reportedtral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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phenotypic heterogeneity occurs due to the variable size
of the duplicated segment and the frequent concomitant
monosomy or other chromosome segment [11].
We report five patients (two of them siblings) with
four different 9p duplications and three of them involv-
ing the centromere of chromosome 9. Two patients
present pure duplication, one presents 9p duplication
associated with 9q deletion and two patients inherited
the derivative chromosome from a maternal transloca-
tion and both present an 18p deletion associated with
the 9p duplication.
Clinical report
Patient 1 (P1)
Male, unique son from a young non-consanguineous
couple and born by cesarean section. At birth, his mea-
surements were: weight of 2,030 g (<3rd centile) and
length of 48 cm (15 th centile) and unknown head circum-
ference. At 7 years, his height of 118.5 cm (3rd centile),
weight was 23,7 Kg (50 th centile) and head circumference
of 47.5 cm (<3rd centile). The clinical evaluation revealed:
microcephaly, downslanting palpebral fissures, bilateral
microtia, broad and prominent nose, bulbous nasal tip,
short philtrum, high palate, scoliosis, bilateral clinodactyly
of the 5 th finger, short median phalanges, dystrophic nails
in feet and micropenis (Figure 1a). At 17 years and nine
months, his height 161.5 of cm (3rd centile); weight was
54,8 Kg, BMI (Body Mass Index) of 21 (15th-50th centile)
and head circumference of 51 cm (<3rd centile). He
evolved with neuropsychomotor delay and presents with
moderated intellectual disability and hipotonia.
Patient 2 (P2)
Female, second child of a young and non-consanguineous
couple. She was born by cesarean section. At birth, her
measurements were: weight of 2,400 g (3rd centile), length
of 49 cm (50th centile) and unknown head circumference.
At 6 years, her weight was 22 kg (75th centile), height of
118 cm (50th centile) and head circumference of 51 cmFigure 1 Patients 1 (a), 2 (b), 3 (c), 4 (d) and 5 (e) at age 14, 5, 7, 17 a(50 th centile). The clinical evaluation revealed: brachy-
cephaly, wide forehead, triangular face, low-set ears,
broad and prominent nasal bridge, ocular hypertelor-
ism, short philtrum, conchal shelf ears, high and narrow
palate, mamarian hypertelorism, bilateral shortening
of 2 th finger in hands, bilateral clynodactyly of 5 th
fingers in hands, and flat feet (Figure 1b). She evolved
with neuropsychomotor delay and recurrent infections.
Patient 3 (P3)
Female, unique child of a young and non-consanguineous
couple. She was born at term by cesarean section after an
uneventful pregnancy. At birth, her measurements were:
weight 2,620 g (15 th - 50 th centile), length of 49 cm
(50 th centile) and head circumference of 32.5 cm (3rd -
15 th centile). At one year, her length was 67 cm (10 th
centile), weight was 6,300 g (<3rd centile) and head
circumference was 44.5 cm (3rd centile). The clinical
evaluation revealed: brachycephaly, wide fontanelles, wide
forehead, flattened face, ocular hypertelorism, inversus
epicanthus, exotropia, low-set and conchal shelf ears,
short nose, long philtrum, kyphosis, brachydactyly, and
ungueal hypoplasia. At six years and nine months, her
length was 99 cm (<3rd centile), weight was 13,950 g (<3rd
centile) and head circumference was 51 cm (50 th centile).
The renal ultrasonography showed bilateral renal hypopla-
sia and the cranial MRI (Magnetic Resonance Imaging) scan
revealed mild cranial asymmetry. She evolved with hypo-
tonia, neuropsychomotor delay and seizures (Figure 1c).
Patient 4 (P4)
Male, first child of a young non-consanguineous couple.
His mother is carrier of a balanced translocation and
had three pregnancies, one of them an abortion. He was
born by cesarean section with birth weight of 3,640 g
(15 th - 50 th centile), birth length of 48 cm (15 th
centile) and unknown head circumference. At 17 years and
three months, the clinical evaluation revealed: height of
163.5 cm (5 th centile); weight of 60 kg, Substitute body
mass index by BMI of 22.22 (50 th-75 th centile) andnd 8, respectively.
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evaluation revealed: brachycephaly, coarse face, prominent
forehead, ocular hypertelorism, downslanting palpebral
fissures, bilateral ptosis, epicanthal folds, prominent nasal
bridge, bulbous nasal tip, short philtrum, low set ears, thick
lips, downturned corners of the mouth, short and webbed
neck, kyphoscoliosis, cryptorchidism, umbilical hernia,
hypermobile joints especially in the fingers, braquidactyly,
clinodactyly, short toes and flat feet (Figure 1d). The oph-
thalmic evaluation detected myopia. He presented with
hypotonia, neuropsychomotor development and speech
delay, and moderate intellectual disability.
Patient 5 (P5)
Female, sister of patient 4, born by cesarean section
with a birth weight of 3,750 g (50 th - 85 th centile);
birth length of 49 cm (50 th centile) and unknown head
circumference. At six years and seven months, the clin-
ical evaluation revealed: height of 101 cm (<1st centile);
weight of 18 kg (15 th centile) and head circumference
of 49 cm (3rd centile). The clinical evaluation revealed:
proportionate short stature, coarse face, prominent
forehead, ocular hypertelorism, exotropia, downslanting
palpebral fissures, bilateral ptosis, bilateral epicanthal
folds, prominent and large nose, bulbous nasal tip, low
set ears, thick lips, large mouth, downturned corners of
the mouth, high arched palate, short and webbed neck,
kyphoscoliosis, hyperflexible joints especially in the
fingers, bilateral clinodactyly of the fifth fingers, short
hands and feet, flat feet and dystrophic nails (Figure 1e).
The ophthalmic evaluation detected myopia. She pre-
sented with hypotonia, neuropsychomotor development
and speech delay, and moderate intellectual disability.
Methods
Classical and molecular cytogenetic study
This study was approved by the ethics committee of the
University Federal of São Paulo (CEP 0389/11). The
parent or guardian of the patients signed the consent
form for participation in the study and to publish
picture. Chromosome analyses were performed on 72-
h lymphocyte cultures for all patients (Table 1) and
their parents. We performed G-banding and FISH in
order to investigate the rearranged chromosomes.
FISH was performed with commercial probes forTable 1 Cytogenomic results for patients with 9p duplication
Patient Cytogenomic data
1 46,XY,der(9;15)t(9;15)(q21.11;p11.2).arr 9p24.3q21.1
2 46,XX,der(9;21)t(9;21)(q21.11;p11.2).arr 9p24.3q21.1
3 46,XX,psu i(9)(p10),der(12)t(9;12)(q21.13;p13.33).arr
4 46,XY,der(18)t(9;18)(p11.1;p11.31)mat.arr 9p24.3q13
5 46,XX,der(18)t(9;18)(p11.1;p11.31)mat.arr 9p24.3q13centromere of the rearranged chromosomes (Cytocell®)
and BAC (Bacterial Artificial Chromosome) probes
RP11-143N16 (9p23) and RP11-373I24 (12p13.33) in
the patient 3 as previously described [13].
Molecular studies
DNA was isolated from peripheral blood using a Gentra
Puregene kit (Qiagen Sciences Inc., Germantown,
MD, USA). High-resolution breakpoint mapping was
performed using Cytoscan HD (Affymetrix Inc., Santa
Clara, CA, USA) according to the manufacturer’s instruc-
tions. The results were analyzed using the Chromosome
Analysis Suite (ChAS) software and annotation GRCh37/
hg19.
Results
Three patients present de novo duplications (P1 to P3),
while two patients - brother and sister (P4 and P5),
present the abnormality inherited from the mother, who
has a balanced translocation (Table 1). G-banding and
FISH revealed a der(9;15) with centromeres from both
chromosomes in P1 (Figure 2a-b), a der(9;21) with also
centromeres from both chromosomes in P2 (Figure 2c-d),
a pseudo-isochromosome 9p with a small centromere and
a der(12)t(9;12) with no deletion in 12p in P3 (Figure 2e, f
and f ’). P4 and P5 presented a maternal der(18)t(9;18)
with a normal chromosome 18 centromere (Figure 2 g-h).
Array results (Table 1) revealed complete 9p duplica-
tion in all patients. However, patient 3 presented a dupli-
cation followed by deletion 9q13→ q21.13, and patients
4 and 5 presented a concomitant 18p deletion due to an
unbalanced translocation between chromosomes 9 and
18. Array showed three copies from 9p to proximal 9q
in all patients (Figure 3). However, since array presents
no probes in the pericentromeric 9p region and its flank-
ing regions are CNVs (Copy Number Variation) rich, we
interpreted the breakpoint as being located at 9q21.11
for P1 and P2, considering that both derivative chromo-
somes are dicentric. For P3, the pseudo-isochromosome
9p presents a fainter FISH signal suggesting the break-
point within the centromere region. This patient also
presents part of the long arm translocated to 12p. For
P4 and P5, the breakpoint was mapped at 9p11.1 since
FISH does not showed centromeric 9p signal in the
derivative chromosome 18 indicating that the break not1 (46,586-69,978,010) × 3
1(203,861-70,990,047) × 3
9p24.3q13(203,861-68,359,990) × 3, 9q13q21.13(68,665,170-76,027,242) × 1
(203,861-68,139,972) × 3, 18p11.32p11.31(136,226-6,426,936) × 1
(203,861-68,139,972) × 3, 18p11.32p11.31(136,226-6,426,936) × 1
Figure 2 Partial G-banding karyotype and FISH results in chromosomes involved in the rearrangements in P1 (a-b), P2 (c-d), P3 (e-f)
and P4 (g-h). Two centromeres were identified in P1 (b) and P2 (d) with centromeric alpha-satellite probes (D9Z1 in red, D15Z1 in green and
D21Z1 in green). P3 (f) showed a monocentric psu i(9p) with D9Z1 in red, the presence of a subtelomeric region in 12p with the RP11-373I24
BAC probe in red and also (f’) two RP11-143N16 probe green signals in the pseudo-isochromosome 9p. P4 (h) showed the der(18) with the
centromere for chromosome 18 (D18Z1 in green). P5, who is P4’s sister, present similar karyotype.
Figure 3 Partial idiogram of chromosome 9 showing the
duplicated regions in black boxes, normal regions in white,
heterochromatin regions in light grey boxes, and a deleted
region in medium grey box. The dark grey boxes represent
duplicated regions according to array results. The breakpoints (*) were
determined by FISH.
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bining all cytogenomic results, we could characterize the
derivative chromosomes as shown in Table 1.
Discussion
Trisomy 9p is a well-recognizable clinical entity and the
facial appearance of patients usually leads to considering
the diagnosis [14]. In general, determining the genotype-
phenotype correlation is often difficult by the presence
of concomitant partial monosomy of other chromosome.
We found two patients with pure trisomy 9p (P1 and P2),
one with concomitant interstitial deletion 9q (P3) and
two with trisomy 9p associated with terminal 18p dele-
tion (P4 and P5).
Table 2 shows the patients reported in the literature in
which the breakpoints were determined precisely with
high resolution techniques. The clinical characteristics
more frequently observed in patients with partial and
Table 2 Clinical features and chromosome breakpoints in patients with partial and complete 9p duplication defined by FISH or array
Features Authors
1 2 3 4 5 6 7 8 9 10 11 12 13 P1 P2 P3 P4 P5
9p duplication 9p22
→
p24
9p22
→
p24
9p22
→
p24
9p22
→
p24
9p22
→
p24
9p24
→
9p21
9p24
→
p12
9p24
→
q13
9p22.3
→
9p23
9p24
→
9q21
9p21.3
→
9p13.2
9p24.3
→
9p13.1
9p24.3
→
p13.1
9p24.3
→
p11.2
9p24.3
→
p13.1
9p24.3→ p13.1
*del9q13→
q21.13
9p24.3→ p13
*del18p11.32p
11.31
9p24.3→ p13
*del18p11.
32p11.31
9 y
(girl)
P1
44 y
(father)
P2
9 m
(boy)
19 m
(girl)
14 y
(boy)
6 y
(boy)
10 m
(boy)
1 m
(girl)
6 y
(girl)
At
birth
(girl)
12 y
(girl)
15 m 13 y
(girl)
14 y
(boy)
6 y
(girl)
6 y (girl) 17 y (boy) 6y (girl)
Microcephaly + + + + + + + - - - -
Brachycephaly + + + + +
Epicanthal folds + + + + + + +
Micrognathia + + + + - -
Downslanting
palpebral fissures
+ + + + + + + + +
Prominent/large
nose
+ + + + + + + + + +
Bulbous nasal tip + + + + + + + + +
Deep set eyes + + + + + + + - -
Hypertelorism + + + + + + +
Low set ears + + + + + + - + + + + +
Malformed ears + + - + +
Downturned
corners of the
mouth
+ + + + - + + +
Thin upper lip + + + + + - -
Short neck + + + + + + + + + + +
Fifth finger short + - +
Nail hypoplasia - - + + + + +
Clinodactyly + + - + + + + + + + + + + +
Brachydactyly + + + +
Neuropsychomotor
development delay
+ + + + + + + + + + + + + +
Hypotonia + + + + + +
Growth delay + + + + + + +
Small penis + +
Speech delay + + + + + + + +
(1-2) Haddad et al. 1996 [9]; (3) Fujimoto et al. 1998 [7]; (4) Guanciali-Franchi et al. 2000 [12]; (5) de Pater et al. 2002 [4]; (6) Sanlaville et al. 1999 [31]; (7) Tsezou et al. 2000 [3]; (8) Teraoka et al. 2001 [8]; (9) Bonaglia et
al. 2002 [17]; (10) Morrissette et al. 2003 [30]; (11) Zou et al. 2009 [15]; (12) Abu-Amero et al. 2010 [16]; (13) Chen et al. 2011 [18]; (14-17) Our patients (P1, P2, P3, P4 and P5); (+) present; (-) absent; ( ) not mentioned in
the paper * (additional deletion).
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nose, bulbous nasal tip, low set ears, short neck, clino-
dactyly, neuropsychomotor development delay and speech
delay. Some other characteristics are rarely reported, such
as strabismus (our P1, P2, P3 and P5), myopia ([15], our
P4 and P5), heart disease [9], epilepsy ([16] and our P3),
dolichocephaly [17], self-injurious behavior [18] and mild
cubitus valgus [15]. The patient described by Bonaglia et
al. [17] presented average intellectual capability and cogni-
tive functions, dolichocephaly, crowded teeth and high
arched palate.
Based on the UCSC Genome Browser database (https://
genome.ucsc.edu), the duplicated region in our patients
contains several annotated genes. DMRT1 (doublesex- and
mab-3-related transcription factor 1) and DMRT2 (double-
sex- and mab-3-related transcription factor 2) are genes
related to gonadal development causing hypospadia,
abnormal external genitalia, or XY sex reversal, as well
as gonadal dysgenesis [19-21]. Only our male patients
(P1 and P4) presented gonadal malformation. FREM1
(FRAS1-related extracellular matrix 1) gene encodes a
basement membrane protein that may play a role in cra-
niofacial and renal development. Although none of our
patients presented renal abnormality, P1 presented
microcephaly and P2, P3 and P4 present brachycephaly.
PSIP1 (PC4 and SFRS1 interacting protein 1), SIGMAR1
(Sigma non-opioid intracellular receptor 1), PAX5
(paired box 5) and CNTNAP3 (contactin associated
protein-like 3) genes are involved in the development
of central nervous system and are responsible for
learning processes, memory and mood alteration. All
of our patients presented intellectual disability. Dele-
tion of FOXD4 (forkhead box D4) gene is associated
with speech and language delays [22] as found in eight
patients from Table 2. The genes described above cause
abnormalities when deleted or mutated. However, in
our patients, these genes are present in three copies,
probably resulting in overexpression of these genes
causing impairment of its function. It is possible that
some of the duplicated genes are dosage-sensitive gene
and the interaction with other factors, such as regu-
latory elements (transcription factors and growth
factors), may contribute to phenotype and cerebral
malformation. In fact, the phenotypic heterogeneity in
trisomy 9p can be caused by the variable expression of
duplicated genes, which can change the development
phenotype [23].
The patient 3 presented a concomitant 9q13-q21.13
deletion which includes genes associated with skeletal
muscle and kidney development such as PGM5 (phos-
phoglucomutase 5), PIP5K1B (phosphatidylinositol-4-
phosphate 5-kinase, type I, beta) and ZFAND5 (zinc
finger, AN1-type domain 5) that may be responsible for
her hypotonia and kidney alteration. The concomitant18p deletion in the patients 4 and 5 includes genes
associated with muscle cell elastic fibers involved in
regulation of contractile activity such as EMILIN2 (elas-
tin microfibril interfacer 2), MYOM1 (myomesin 1) and
MYL12B (myosin, light chain 12B), probably responsible
for their hyperlaxity, hiperextensible fingers and hyper-
flexible joints.
In most patients, the 9p duplicated segment is
derived from a parental reciprocal balanced transloca-
tion and is accompanied by a concurrent deletion of
another chromosome, such as in our patients 3 to 5,
who additionally to the 9p duplication, presented a
deletion. For P4 and P5, the deletion seems to be more
relevant to their clinical features causing short stature,
microcephaly, round face, ptosis and downslanting
palpebral fissures. Pure de novo duplications of 9p - as
in our patients 1 and 2 - are rare, and there are only 15
patients reported [16].
The pericentromeric region of chromosome 9 is
especially rich in segmental duplications or low copy
repeats (LCR) that predispose it to non-allelic homolo-
gous recombination (NAHR) resulting in a high fre-
quency of polymorphic variants located adjacent to the
centromere [24], with pericentric inversions (49.4%)
being the most frequent alterations [25]. In order to
explain our rearranged chromosomes 9, we must
consider that at least 5% of the human genome consists of
interspersed duplications, either between non-homologous
chromosomes (transchromosomal duplications), or re-
stricted to a particular chromosome (chromosome-
specific duplications) (Eichler, 2001). In our cases P1
and P2 the unequal recombination between nonhomol-
ogous chromosomes would have probably originated
9p duplication that rearranged with other chromosome
by NHEJ (nonhomologous end-joining) mechanism
possibly due to homology between the breakpoints.
Among the interchromosomal segmental duplications,
there are some in chromosome 9 with high degree
of sequence identity at the nucleotide level DNA to
sequences in the pericentromeric region of the short
arm of chromosomes 15, 18 and 21, the chromosomes
involved in our rearrangements [26-28]. Thus, we
suggest that these interchromosomal segmental duplica-
tions located in chromosome 9 within the pericentromeric
inversion variant, and within the pericentromeric se-
quences of nonhomologous chromosomes predisposed
to illegitimate recombination between them, resulting
in the dicentric chromosomes in our P1 and P2 with
9p duplication (Figure 4). These chromosomes may
be converted into a stable functional monocentric
chromosome by epigenetic centromere inactivation
followed by heterochromatinization, which suppresses
the revival of centromere activity, as proposed by Sato
et al. [29] in chromosomes in yeast.
Figure 4 Schematic presentation showing a proposal mechanism for 9p duplication origin in patients 1 and 2.
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smaller centromere than its homologous, suggesting
that the break occurred in the centromere. Probably
the deletion 9q (P3) resulted from an error during the
translocation with chromosome 12. Patients P4 and
P5 inherited a derivative chromosome 18 from their
mother. Littooij et al. [11] suggested that the rela-
tively high frequency of partial trisomy 9p is not the
result of an increased frequency of recombination
events due to breakage sensitive regions on 9p, but
rather the result of postmeiotic survival of relatively
viable zygotes.
FISH was essential to define the rearrangement
around the centromeric region of chromosome 9 be-
cause arrays do not present probes for the heterochro-
matin region due to high level of repetitive elements.
Moreover, there is a copy number variation around this
region making it difficult to interpret the array data.
We believe that 9p duplication associated to dicentric
chromosomes must be a much more common event
than thought since many reported rearranged chromo-
somes may be insufficiently characterized.
Conclusion
The patients with trisomy 9p present a well-recognizable
phenotype, however the genotype-phenotype correlation
can be difficult due to concomitant partial monosomy
of other chromosomes, and the possibility of some of
the duplicated genes are dosage-sensitive which may
influence the phenotype. The use of microarray to-
gether with FISH technology was critical for the proper
identification and precise molecular characterization
of the rearranged chromosomes in order to betterdefine the critical regions, leading to more accurate
genotype/phenotype correlations and understanding of
the mechanisms involved in these genomic imbalances.
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